Could thiamine pyrophosphate be a regulator of the nitric oxide synthesis in the endothelial cell of diabetic patients?

Medical Hypotheses

Volumn 76, Issue 5, 2011, Pages 629-631

  Alcázar Leyva, Susana ^a   Alvarado Vásquez, Noé ^b  

^a Hans Selye   (Mexico)

^b INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BENFOTIAMINE; COCARBOXYLASE; GLUCOSE; NITRIC OXIDE; OXOGLUTARATE DEHYDROGENASE; PENTOSE; PYRUVATE DEHYDROGENASE; THIAMINE; THIAMINE PYROPHOSPHOKINASE; TRANSKETOLASE;

ARTICLE; BLOOD VESSEL INJURY; CELL PROTECTION; CELL TYPE; CELL VIABILITY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC PATIENT; ENDOTHELIUM CELL; ENERGY CONSUMPTION; ENZYME PHOSPHORYLATION; GLUCOSE METABOLISM; HUMAN; MITOCHONDRION; PHOSPHORYLATION; RISK REDUCTION; SYNTHESIS; THIAMINE DEFICIENCY;

CELL SURVIVAL; DIABETES COMPLICATIONS; DIABETES MELLITUS; ENDOTHELIAL CELLS; ENZYME ACTIVATION; HUMANS; MODELS, BIOLOGICAL; MYOCARDIAL INFARCTION; NITRIC OXIDE; PENTOSE PHOSPHATE PATHWAY; PHOSPHORYLATION; THIAMINE; THIAMINE PYROPHOSPHATE;

EID: 79954422336     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.01.015     Document Type: Article

References (45)

1. Jansen B., Donath W. Geneeskundig Tijdschrift Voor Nederlandsch-Indie 1926, 66:1-2. [Reprinted as: The isolation of the anti beri beri vitamin. Nutr Rev 1982; 40:53-55].
2. Bender D.A. Optimum nutrition: thiamin, biotin and pantothenate. Proc Nutr Soc 1999, 58:427-433.
3. Rindi G., Laforenza U. Thiamine intestinal transport and related issues: recent aspects. Proc Soc Exp Biol Med 2000, 224:246-255.
4. Paparrigopoulos T., Tzavellas E., Karaiskos D., Kouzoupis A., Liappas I. Complete recovery from undertreated Wernicke-Korsakoff syndrome following aggressive thiamine treatment. In Vivo 2010, 24:231-233.
5. Boniol S., Boyd M., Koreth R., Burton G.V. Wernicke encephalopathy complicating lymphoma therapy: case report and literature review. South Med J 2007, 100:717-719.
6. Vognar L., Stoukides J. The role of low plasma thiamin levels in cognitively impaired elderly patients presenting with acute behavioral disturbances. J Am Geriatr Soc 2009, 57:2166-2168.
7. Hanninen S.A., Darling P.B., Sole M.J., Barr A., Keith M.E. The prevalence of thiamin deficiency in hospitalized patients with congestive heart failure. J Am Coll Cardiol 2006, 47:354-361.
8. Bettendorff L., Wins P. Thiamin diphosphate in biological chemistry: new aspects of thiamin metabolism, especially triphosphate derivatives acting other than as cofactors. FEBS J 2009, 276:2917-2925.
9. Thornalley P.J. The potential role of thiamine (vitamin B1) in diabetic complications. Curr Diabetes Rev 2005, 1:287-298.
10. Ganapathy V., Smith S.B., Prasad P.D. SLC19: the folate/thiamine transporter family. Pflugers Arch 2004, 447:641-646.
11. Onal H., Bariş S., Ozdil M., Yeşil G., Altun G., Ozyilmaz I., et al. Thiamine-responsive megaloblastic anemia: early diagnosis may be effective in preventing deafness. Turk J Pediatr 2009, 51:301-304.
12. Rindi G., Patrini C., Laforenza U., Mandel H., Berant M., Viana M.B., et al. Further studies on erythrocyte thiamin transport and phosphorylation in seven patients with thiamin-responsive megaloblastic anaemia. J Inherit Metab Dis 1994, 17:667-677.
13. Pekovich S.R., Martin P.R., Singleton C.K. Thiamine deficiency decreases steady-state transketolase and pyruvate dehydrogenase but not alpha-ketoglutarate dehydrogenase mRNA levels in three human cell types. J Nutr 1998, 128:683-687.
14. Alexander-Kaufman K., Harper C. Transketolase: observations in alcohol-related brain damage research. Int J Biochem Cell Biol 2009, 41:717-720.
15. Debray F.G., Lambert M., Gagne R., Maranda B., Laframboise R., MacKay N., et al. Pyruvate dehydrogenase deficiency presenting as intermittent isolated acute ataxia. Neuropediatrics 2008, 39:20-23.
16. Rigalleau V., Beauvieux M.C., Gallis J.L., Gin H., Schneiter P., Tappy L. Glucose flux in controlled hyperglycaemia before and after oral glucose ingestion in men with mild type 2 diabetes. Diabetes Metab 2010, 36:234-239.
17. Thornalley P.J., Babaei-Jadidi R., Al Ali H., Rabbani N., Antonysunil A., Larkin J., et al. High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease. Diabetologia 2007, 50:2164-2170.
18. Saito N., Kimura M., Kuchiba A., Itokawa Y. The relationship between blood thiamine levels and dietary thiamine content in diabetic outpatients and healthy subjects. J Nutr Sci Vitaminol (Tokyo) 1987, 33:431-438.
19. Lorber A., Gazit A.Z., Khoury A., Schwartz Y., Mandel H. Cardiac manifestations in thiamine-responsive megaloblastic anemia syndrome. Pediatr Cardiol 2003, 24:476-481.
20. Babaei-Jadidi R., Karachalias N., Ahmed N., Battah S., Thornalley P.J. Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine. Diabetes. 2003, 52(8):2110-2120.
21. Balakumar P., Chakkarwar V.A., Singh M. Ameliorative effect of combination of benfotiamine and fenofibrate in diabetes-induced vascular endothelial dysfunction and nephropathy in the rat. Mol Cell Biochem 2009, 320:149-162.
22. Naggar H., Ola M.S., Moore P., Huang W., Bridges C.C., Ganapathy V., et al. Downregulation of reduced-folate transporter by glucose in cultured RPE cells and in RPE of diabetic mice. Invest Ophthalmol Vis Sci 2002, 43:556-563.
23. Sanioto S.M., Reinauer H., Hollmann S. Thiamine pyrophosphokinase activity in liver, heart and brain crude extracts of control and thiamine deficient rats. Int J Vitam Nutr Res 1977, 47:315-324.
24. Babaei-Jadidi R., Karachalias N., Kupich C., Ahmed N., Thornalley P.J. High-dose thiamine therapy counters dyslipidaemia in streptozotocin-induced diabetic rats. Diabetologia 2004, 47:2235-2246.
25. Lindhurst M.J., Fiermonte G., Song S., Struys E., De Leonardis F., Schwartzberg P.L., et al. Knockout of Slc25a19 causes mitochondrial thiamine pyrophosphate depletion, embryonic lethality, CNS malformations, and anemia. Proc Natl Acad Sci USA 2006, 103:15927-15932.
26. Barile M., Valenti D., Brizio C., Quagliariello E., Passarella S. Rat liver mitochondria can hydrolyse thiamine pyrophosphate to thiamine monophosphate which can cross the mitochondrial membrane in a carrier-mediated process. FEBS Lett 1998, 435:6-10.
27. Song Q., Singleton C.K. Mitochondria from cultured cells derived from normal and thiamine-responsive megaloblastic anemia individuals efficiently import thiamine diphosphate. BMC Biochem 2002, 3:8.
28. Cura A.J., Carruthers A. Acute modulation of sugar transport in brain capillary endothelial cell cultures during activation of the metabolic stress pathway. J Biol Chem 2010, 285:15430-15439.
29. Yao D., Brownlee M. Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands. Diabetes 2010, 59:249-255.
30. Lassègue B., Griendling K.K. NADPH oxidases: functions and pathologies in the vasculature. Arterioscler Thromb Vasc Biol 2010, 30:653-661.
31. Nishikawa T., Kukidome D., Sonoda K., Fujisawa K., Matsuhisa T., Motoshima H., et al. Impact of mitochondrial ROS production on diabetic vascular complications. Diabetes Res Clin Pract 2007, 77(Suppl 1):S41-S45.
32. Nishikawa T., Edelstein D., Du X.L., Yamagishi S., Matsumura T., Kaneda Y., et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000, 404:787-790.
33. Alvarado-Vásquez N., Páez A., Zapata E., Alcázar-Leyva S., Zenteno E., Massó F., et al. HUVECs from newborns with a strong family history of diabetes show diminished ROS synthesis in the presence of high glucose concentrations. Diabetes Metab Res Rev 2007, 23:71-80.
34. Gaudreault N., Scriven D.R., Laher I., Moore E.D. Subcellular characterization of glucose uptake in coronary endothelial cells. Microvasc Res 2008, 75:73-82.
35. Bolaños J.P., Almeida A. The pentose-phosphate pathway in neuronal survival against nitrosative stress. IUBMB Life 2010, 62:14-18.
36. Tylicki A., Czerniecki J., Godlewska A., Kieliszek M., Zebrowski T., Bielawski T., et al. Changes in ECG and enzyme activity in rat heart after myocardial infarction: effect of TPP and MnCl2. J Physiol Biochem 2008, 64:93-101.
37. Cappelli-Bigazzi M., Battaglia C., Pannain S., Chiariello M., Ambrosio G. Role of oxidative metabolism on endothelium-dependent vascular relaxation of isolated vessels. J Mol Cell Cardiol 1997, 29:871-879.
38. Alcázar M.H., Alcázar L.S. Usefulness of thiamine pyrophosphate (cocarboxylase) solution-stable on two cases of postmyocardial infarction. Inv Med Int 1991, 17:170-180.
39. Alcázar M.H., Alcázar L.S. Thiamine pyrophosphate as a preventive and regenerative therapy in the aging of diabetics. Inv Med Int 1991, 17:195-199.
40. Baker H.D., Scholte H.R., Luyt-Houwen Van., Gennip A.H., Abeling N.G., Lamb J. Neonatal cardiomyopathy and lactic acidosis responsive to thiamine. J Inherit Metab Dis 1964, 14:75-79.
41. Toyoshima M., Oka A., Egi Y., Yamamoto T., Onozuka M., Nosaka K., et al. Thiamine-responsive congenital lactic acidosis: clinical and biochemical studies. Pediatr Neurol 2005, 33:98-104.
42. Chornyy S., Parkhomenko J., Chorna N. Thiamine deficiency caused by thiamine antagonists triggers upregulation of apoptosis inducing factor gene expression and leads to caspase 3-mediated apoptosis in neuronally differentiated rat PC-12 cells. Acta Biochim Pol 2007, 54:315-322.
43. Romero I.A., Rist R.J., Aleshaiker A., Abbott N.J. Metabolic and permeability changes caused by thiamine deficiency in immortalized rat brain microvessel endothelial cells. Brain Res 1997, 756:133-140.
44. Beltramo E., Berrone E., Tarallo S., Porta M. Effects of thiamine and benfotiamine on intracellular glucose metabolism and relevance in the prevention of diabetic complications. Acta Diabetol 2008, 45:131-141.
45. Marchetti V., Menghini R., Rizza S., Vivanti A., Feccia T., Lauro D., et al. Benfotiamine counteracts glucose toxicity effects on endothelial progenitor cell differentiation via Akt/FoxO signaling. Diabetes 2006, 55:2231-2237.